FLT3 and neoplasm: The FLT3 c.2541+58 A > G (V1) and FLT3 c.2053+85_2053+88del (V2) polymorphisms were chosen as markers, which were heterozygous in donor cells and homozygous in patient cells, including tumor cells, as found in the sample before HSCT.